Proyeksi Harga Lycia Therapeutics Inc(LYCA) & Analisis Perusahaan - PER·Dividen·Kinerja·Target Harga·RSI·MACD | Saham AS Hari Ini
LYCA
Baru Lycia Therapeutics Inc
$30.00
+12.00 ▲ +66.67%
26 Okt pukul 7:59 AM ET (Korea 10/26 20:59)$26.88
-3.12 ▼ -10.40%
Tabel metrik lengkap
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | 52.1M | Perf Week | - |
| Market Cap | 1.56B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | - |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | - |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | - | Perf YTD | - |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | - | Perf Year | - |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | - | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 14.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | - | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | 0% ($30) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | 0% ($30) | Rel Volume | - | Prev Close | $18 |
| Employees | 65 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 0% ($30) | Avg Volume(3M) | - | Price | $30 |
| IPO | 2026/10/23 | Option/Short | No/No | Trades | 19923 | Volume | 2,287,448 | Change | 66.67% |
Info perusahaan
Lycia Therapeutics IncLYCA | NASD | Biotechnology 🧬 세포 밖으로 분비된 단백질을 리소좀으로 끌어들여 분해하는 플랫폼을 보유한 임상 단계 바이오테크입니다. 스탠퍼드대 연구진의 기반 기술에서 출발해 자가면역·염증·알레르기 질환을 겨냥하며, 미국 캘리포니아 사우스샌프란시스코에 본사를 두고 나스닥에 상장되어 있습니다.
Harga
Dalam 1 tahun terakhir, sedang
Posisi 52 Minggu-
Volume 2,287,448
Apakah trennya naik jangka panjang? B
Kinerja jangka panjangnya cenderung datar
Ketuk untuk melihat angka
Bagaimana dividennya?
Tidak ada dividen
Belum ada laba untuk dibagikan.
Siapa saja pemiliknya? B
Kepemilikannya biasa saja
Panduan Komposisi Pemegang Saham
Ketuk untuk melihat angka
Perbandingan Sektor Biotechnology
Di sektor ini, merupakan perusahaan terbesar ke-122 dari 595
Berdasarkan kapitalisasi pasar $2B.
TRAXKe-119 First Tracks Biotherapeutics Inc $2B PER - 
ABSIKe-120 Absci Corp $2B PER - 
NTLAKe-121 Intellia Therapeutics Inc $2B PER - LYCAKe-122 Lycia Therapeutics Inc $2B PER - 
QUREKe-123 uniQure NV $2B PER - Artikel terkait saham ini 1 kiriman
Pertanyaan Umum
Sinyal & pasar, paling awal Saluran Telegram · KakaoTalk
